[1] Tang, S.C., Chan, G.C. and Lai, K.N. (2016) Recent Advances in Managing and Understanding Diabetic Nephropathy. F1000 Research, 5, 1000-1044.
https://doi.org/10.12688/f1000research.7693.1
[2] Stephens, J.W. (2005) The D Allele of the ACE/ID Common Gene Variant Is Associated with T2D Mellitus in Caucasian Subjects. Molecular Genetics and Metabolism, 84, 83-88.
https://doi.org/10.1016/j.ymgme.2004.09.002
[3] Chiarelli, F., Gaspari, S. and Marcovecchio, M.L. (2009) Role of Growth Factors in Diabetic Kidney Disease. Hormone and Metabolic Research, 41, 585-593.
https://doi.org/10.1055/s-0029-1220752
[4] Sun, J., Xu, Y., Zhu, Y. and Lu, H. (2004) Genetic Polymorphism of Methylenetetrahydrofolate Reductase as a Risk Factor for Diabetic Nephropathy in Chinese Type 2 Diabetic Patients. Diabetes Research and Clinical Practice, 64, 185-190.
https://doi.org/10.1016/j.diabres.2003.10.022
[5] Freedman, B.I., Bowden, D.W., Rich, S.S., Valis, C.J., Sale, M.M., Hicks, P.J., et al. (2005) A Genome Scan for All-Cause End-Stage Renal Disease in African Americans. Nephrology Dialysis Transplantation, 20, 712-718.
https://doi.org/10.1093/ndt/gfh704
[6] Parvanova, A., Iliev, I., Dimitrov, B.D., Arnoldi, F., Zaletel, J., Remuzzi, G. and Ruggenenti, P. (2002) Hyperhomocysteinemia and Increased Risk of Retinopathy: A Cross-Sectional, Case-Control Study in Patients with Type 2 Diabetes. Diabetes Care, 25, 2361.
https://doi.org/10.2337/diacare.25.12.2361
[7] Mtiraoui, N., Ezzidi, I., Chaieb, M., Marmouche, H., Aouni, Z., Chaieb, A., Mahjoub, T., Vaxillaire, M. and Almawi, W.Y. (2007) MTHFR C677T and A1298C Gene Polymorphisms and Hyperhomocysteinemia as Risk Factors of Diabetic Nephropathy in Type 2 Diabetes Patients. Diabetes Research and Clinical Practice, 75, 99-106.
https://doi.org/10.1016/j.diabres.2006.05.018
[8] Wang, F., Maggie, Y., Wing, N.S., et al. (2005) Prognostic Effect of Insertion/Deletion Polymorphism of the ACE Gene on Renal and Cardiovascular Clinical Outcomes in Chinese Patients with Type-2 Diabetes. Diabetes Care, 54, 301-306.
[9] Chang, H.R., Cheng, C.H., Shu, K.H., Chen, C.H., Lien, J.D. and Wu, M.Y. (2003) Study of the Polymorphism of Angiotensinogen, Angiotensin Converting Enzyme and Angiotensin Receptor in Type II Diabetes with End-Stage Renal Disease in Taiwan. Journal of the Chinese Medical Association, 66, 51-56.
[10] Klemm, T., Mittrach-Schorins, S., Neumann, S., Gerike, T., krankenberg, H., Schuler, G., et al. (2003) No Association between the Angiotensin-Converting-Enzyme Gene Insertion/Deletion Polymorphism and the Occurrence of Macroangiopaty in Patients with Diabetes Mellitus Type 2. Hormone and Metabolic Research, 35, 43-47.
https://doi.org/10.1055/s-2003-38390
[11] Zhu, X., Chang, Y., Yan, D., Weder, A., Cooper, R., Luke, A., et al. (2003) Associations between Hypertension and Genes in the Rennin Angiotensin System. Hypertension, 41, 1027-1037.
https://doi.org/10.1161/01.HYP.0000068681.69874.CB
[12] Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A Simple Salting out Procedure for Extracting DNA from Human Nucleated Cells. Nucleic Acids Research, 16, 12-15.
https://doi.org/10.1093/nar/16.3.1215
[13] Tanaka, C., Kamide, K., Takiachi, S., Miwa, Y., Yoshiim, M., Kawano, Y., et al. (2003) An Alternative Fast and Convenient Genotyping Method for the Screening of Angiotensin Converting Enzyme Gene Polymorphism. Hypertension Research, 26, 301-306.
https://doi.org/10.1291/hypres.26.301
[14] Tanaka, N. and Babazono, T. (2005) Assessing Genetic Susceptibility to Diabetic Nephropathy. Nephrology, 10, S17-S21.
https://doi.org/10.1111/j.1440-1797.2005.00451.x
[15] Erdös, E.G. and Skidgel, R.A. (1987) The Angiotensin I Converting Enzyme. Laboratory Investigation, 56, 345-348.
[16] Födinger, M., Hörl, W.H. and Sunder-Plassmann, G. (2000) Molecular Biology of 5,10-Methylenetetrahydrofolate Reductase. Journal of Nephrology, 13, 20-33.
[17] Palomo-Piñón, S., Gutiérrez-Rodríguez, M.E., Díaz-Flores, M., Sánchez-Barrera, R., Valladares-Salgado, A., Utrera-Barillas, D., Durán-Reyes, G., Galván-Duarte, R.E., Trinidad-Ramos, P. and Cruz, M. (2009) DD Genotype of Angiotensin-Converting Enzyme in Type 2 Diabetes Mellitus with Renal Disease in Mexican Mestizos. Nephrology (Carlton), 14, 235-239.
https://doi.org/10.1111/j.1440-1797.2008.01034.x
[18] Movva, S., Alluri, R.V., Komandur, S., Vattam, K., Eppa, K., Mukkavali, K.K., Mubigonda, S., Saharia, S., Shastry, J.C. and Hasan, Q. (2007) Relationship of Angiotensin-Converting Enzyme Gene Polymorphism with Nephropathy Associated with Type 2 Diabetes Mellitus in Asian Indians. Journal of Diabetes and Its Complications, 21, 237-241.
https://doi.org/10.1016/j.jdiacomp.2006.07.001
[19] Ha, S.K., Park, H.C., Park, H.S., Kang, B.S., Lee, T.H., Hwang, H.J., Kim, S.J., Kim, D.H., Kang, S.W., Choi, K.H., Lee, H.Y. and Han, D.S. (2003) ACE Gene Polymorphism and Progression of Diabetic Nephropathy in Korean Type 2 Diabetic Patients: Effect of ACE Gene DD on the Progression of Diabetic Nephropathy. American Journal of Kidney Diseases, 41, 943-949.
https://doi.org/10.1016/S0272-6386(03)00191-4
[20] Kuramoto, N., Iizuka, T., Ito, H., Yagui, K., Omura, M., Nozaki, O., Nishikawa, T., Tsuchida, H., Makino, H., Saito, Y. and Kanatsuka, A. (1999) Effect of ACE Gene on Diabetic Nephropathy in NIDDM Patients with Insulin Resistance. American Journal of Kidney Diseases, 33, 276-281.
https://doi.org/10.1016/S0272-6386(99)70300-8
[21] Mizuiri, S., Hemmi, H., Inoue, A., Yoshikawa, H., Tanegashima, M., Fushimi, T., Ishigami, M., Amagasaki, Y., Ohara, T., Shimatake, H., et al. (1995) Angiotensin-Converting Enzyme Polymorphism and Development of Diabetic Nephropathy in Non-Insulin-Dependent Diabetes Mellitus. Nephron, 70, 455-459.
https://doi.org/10.1159/000188645
[22] Arfa, I., Abid, A., Nouira, S., Elloumi-Zghal, H., Malouche, D., Mannai, I., Zorgati, M.M., Ben, Alaya, N., Rebai, A., Zouari, B., Ben, Ammar, S., Ben, Rayana, M.C., Hmida, S., Blousa-Chabchoub, S. and Abdelhak, S. (2008) Lack of Association between the Angiotensin-Converting Enzyme Gene (I/D) Polymorphism and Diabetic Nephropathy in Tunisian Type 2 Diabetic Patients. Journal of the Renin-Angiotensin-Aldosterone System, 9, 32-36.
https://doi.org/10.3317/jraas.2008.002
[23] Liao, L., Lei, M.X. and Chen, H.L. (2003) Angiotensin Converting Enzyme Gene Polymorphism and Type 2 Diabetic Nephropathy. Bulletin of Hunan Medical University, 28, 553-556.
[24] Araz, M., Aynacioglu, S., Okan, V., Akdemir, I., et al. (2002) Angiotensin-Converting Enzyme Gene Polymorphism and Coronary Heart Disease in Turkish Type 2 Diabetic Patients. Acta Cardiologica, 57, 265-269.
https://doi.org/10.2143/AC.57.4.2005424
[25] Grzeszczak, W., Zychma, M.J., Lacka, B. and Zukowska-Szczechowska, E. (1998) Angiotensin I-Converting Enzyme Gene Polymorphisms: Relationship to Nephropathy in Patients with Non-Insulin Dependent Diabetes Mellitus. Journal of the American Society of Nephrology, 9, 1664-1669.
[26] Schmidt, S. and Ritz, E. (1997) Angiotensin I Converting Enzyme Gene Polymorphism and Diabetic Nephropathy in Type II Diabetes. Nephrology Dialysis Transplantation, 12, 37-41.